130 likes | 240 Views
OSARM Opportunities for Junior Faculty Members in 2012-2013. Friday, July 27, 2012 Dr. Sally Rigler Seminar Series Office of Scholarly, Academic & Research Mentoring (OSARM). Goals for today. Reminder re: OSARM structure & function Incubator Faculty—already started by now
E N D
OSARM Opportunities for Junior Faculty Members in 2012-2013 Friday, July 27, 2012 Dr. Sally Rigler Seminar Series Office of Scholarly, Academic & Research Mentoring (OSARM)
Goals for today • Reminder re: OSARM structure & function • Incubator Faculty—already started by now • IM-Seed-20 Award opportunity • IM-RCA-75 Award opportunity
Purpose of OSARM Office of Scholarly Academic & Research Mentoring Increased emphasis on ‘mentoring toward promotion’ and scholarly productivity for all
OSARM OSARM Research Career Awardees (75% research time) 1 new award/year Seed Grant Awardees (20% research time) 1 new award/year Incubator Faculty Members • ~15-20 persons All Department of Medicine Assistant Professors Mentor/mentee meetings n=80
Seminar Series in 2012-2013 • Targeted to Incubator, Seed and RCA Faculty • Other IM Faculty members are welcome • All sessions Friday noon with lunch • Fall: Core academic & research content • E.g., Project Roadmap, HSC, P&T, Faculty Assessment • Spring: Scholars’ own work • Work in progress is fine; good opportunity for feedback
OSARM Incubator • 13 faculty members in 2012-13 • Project mentoring & Career Mentoring • Two year duration, with progress in year 1 • Expectations: at least 1 paper each year • Proposed time line/Memo of understanding • Should be returned to OSARM by now • Encouraged to revise time-line and review often
IM-Seed-20 • E-LOI to Dr. Rigler due Friday, August 3rd 5 pm • Purpose: to provide pilot funds and research experience for future larger applications • Year-long writing & application process • 1 award per year planned • Duration one year only, not renewable • Would start July 1, 2013 (with IRB approval) • Requires 20% research time protection
IM-Seed-20, continued • Award $52,620: • $30,000 in justifiable project costs • $ 1,500 for career development activity/travel • $21,120 toward salary + fringe ($16,000 salary) which is 0.1 EVU equivalent at present • Division must cover the remaining salary gap and 20% time must be protected for this project • This must be crystal clear in the application process • Scope of project must be right for the amount of $ and time and other resources available
IM-RCA-75 • E-LOI due to Dr. Rigler Friday August 3rd at 5 pm • Year-long writing & application process • 1 award per year planned • A second year may be possible, with evidence of strong progress in year 1 and continued need • Would start July 1, 2013 (with IRB approval) • Requires 75% research time commitment • Intended for those persons who are planning for heavily research careers & pursuing own grants
IM-RCA-75, continued • Award $127,480 • $40,000 in justifiable project costs • $ 3,000 for career development activity/travel • $84,480 toward salary + fringe ($64,000 salary) which is 0.4 EVU equivalent (16K per 0.2 EVU) • Division must cover the remaining salary gap and 75% time must be protected for this project • Gap will vary depending on level of compensation/specialty • This must be crystal clear in the application process • Scope of project must be appropriate for funds, time and other resources available
Additional Expectations for RCA: • Must be willing to write subsequent NIH K08/K23 or equivalent academic career development award proposals via foundations • Think of RCA as a “Pre-K” • We provide an external NIH-style review • 2 years in which to obtain external career award • Must submit external awards quickly or there will not be time to actually get one by the end of RCA award • Then K08 or K23: 5 years of 75% time protection • During which you then pursue independent R01 etc.
Seed & RCA Preparation Process for 2012-13 Academic Year • See Handouts for multi-step process: • E-LOI August 3rd • Planning meetings (SR, JM) September 28 • First complete draft due November 16 • Written feedback to you December 21 • Revised final draft due February 1 • External review Feb-March • Announcement ~ early May • Earliest start date July 1, 2013